« Back to Record
Classe, J. M., Meeus, P., Hudry, D., Wernert, R., Quenet, F., Marchal, F., Houvenaeghel, G., Bats, A. S., Lécuru, F., Ferron, G., Brigand, C., Berton, D., Gladieff, L., Joly, F., Ray-Coquard, I., Durand-Fontanier, S., Liberale, G., Pocard, M., Georgeac, C., Gouy, S., Guilloit, J. M., Guyon, F., Costan, C., Rousselet, J. M., de Guerké, L., Bakrin, N., Brument, E., Martin, E., Asselain, B., Campion, L., & Glehen, O. (2024). Hyperthermic intraperitoneal chemotherapy for recurrent ovarian cancer (CHIPOR): a randomised, open-label, phase 3 trial. Lancet oncology, 25(12), 1551-1562. doi:10.1016/S1470-2045(24)00531-X
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/387460



